Murata Manufacturing Co., Ltd. (MRAAF)

Achilles Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	519,594	625,148	622,007	318,557	370,388	363,979
Short-Term Investments	-	-	-	174,696	198,053	86,817
Cash & Short-Term Investments	519,594	625,148	622,007	493,253	568,441	450,796
Cash Growth	-3.36%	0.51%	26.10%	-13.23%	26.10%	19.84%
Receivables	290,913	294,419	292,736	270,618	358,310	340,871
Inventory	489,202	482,833	513,024	575,026	464,723	361,331
Prepaid Expenses	-	-	-	68,390	43,662	-
Other Current Assets	107,914	95,535	71,995	803	70	31,182
Total Current Assets	1,407,623	1,497,935	1,499,762	1,408,090	1,435,206	1,184,180
Property, Plant & Equipment	1,239,584	1,247,931	1,244,010	1,188,198	1,116,602	1,078,838
Long-Term Investments	231	53,260	70,476	30,365	34,618	56,865
Goodwill	133,276	135,746	137,144	126,839	118,014	71,058
Other Intangible Assets	40,297	40,647	39,049	44,387	47,141	33,524
Long-Term Deferred Tax Assets	55,995	52,675	47,454	31,885	26,562	37,796
Other Long-Term Assets	55,777	-	-	42,999	31,028	-
Total Assets	2,932,783	3,028,194	3,037,895	2,872,763	2,809,171	2,462,261
Accounts Payable	67,751	69,617	67,620	65,597	93,842	85,927
Accrued Expenses	-	-	-	154,507	152,107	52,909
Short-Term Debt	-	-	-	-	-	97
Current Portion of Long-Term Debt	977	781	50,400	59,981	-	39,982
Current Portion of Leases	10,336	10,043	9,256	8,064	6,375	6,955
Current Income Taxes Payable	23,142	30,952	26,966	14,184	59,228	41,525
Current Unearned Revenue	882	883	883	-	-	-
Other Current Liabilities	138,028	164,241	162,492	1,264	9,706	90,516
Total Current Liabilities	241,116	276,517	317,617	303,597	321,258	317,911
Long-Term Debt	1,544	1,656	2,436	51,464	110,979	110,625
Long-Term Leases	47,526	47,513	43,848	35,033	25,627	25,051
Long-Term Deferred Tax Liabilities	10,979	12,081	10,946	10,601	13,233	7,603
Other Long-Term Liabilities	18,458	35,618	36,760	6,331	9,596	5,421
Total Liabilities	414,711	448,219	482,286	470,287	545,259	540,616
Common Stock	69,444	69,444	69,444	69,444	69,444	69,444
Additional Paid-In Capital	99,601	99,354	121,231	121,116	121,004	120,880
Retained Earnings	2,394,527	2,400,684	2,332,018	2,186,040	2,024,368	1,786,660
Treasury Stock	-172,564	-135,192	-133,441	-133,494	-53,538	-53,552
Comprehensive Income & Other	128,032	146,515	166,895	159,405	102,318	-2,627
Total Common Equity	2,519,040	2,580,805	2,556,147	2,402,511	2,263,596	1,920,805
Minority Interest	-968	-830	-538	-35	316	840
Shareholders' Equity	2,518,072	2,579,975	2,555,609	2,402,476	2,263,912	1,921,645
Total Liabilities & Equity	2,932,783	3,028,194	3,037,895	2,872,763	2,809,171	2,462,261
Total Debt	60,383	59,993	105,940	154,542	142,981	182,710
Net Cash (Debt)	459,211	565,155	516,067	338,711	425,460	268,086
Net Cash Growth	6.69%	9.51%	52.36%	-20.39%	58.70%	91.37%
Net Cash Per Share	246.63	302.39	273.17	178.61	221.66	139.67
Filing Date Shares Outstanding	1,844	1,852	1,879	1,889	1,919	1,919
Total Common Shares Outstanding	1,844	1,862	1,889	1,889	1,919	1,919
Working Capital	1,166,507	1,221,418	1,182,145	1,104,493	1,113,948	866,269
Book Value Per Share	1365.80	1385.77	1353.01	1271.73	1179.27	1000.71
Tangible Book Value	2,345,467	2,404,412	2,379,954	2,231,285	2,098,441	1,816,223
Tangible Book Value Per Share	1271.69	1291.06	1259.75	1181.09	1093.23	946.22
Land	-	-	-	85,649	81,213	-
Buildings	-	-	-	846,923	789,142	-
Machinery	-	-	-	1,609,043	1,530,121	-
Construction In Progress	-	-	-	135,966	89,723	-
Order Backlog	-	287,495	310,147	339,758	-	434,314

Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.